Fibroblast growth factor receptor 2 with Apert mutation (S252W) increase osteoblast differentiation and mineralization.

被引：0
|
作者：
Tanimoto, Y [1 ]
Yokozeki, M [1 ]
Hiura, K [1 ]
Moriyama, K [1 ]
机构：
[1] Univ Tokushima, Sch Dent, Dept Orthodont, Tokushima 770, Japan
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F197
引用
收藏
页码：S194 / S194
页数：1
相关论文
共 50 条
  • [41] Ocular anterior chamber dysgenesis in craniosynostosis syndromes with a fibroblast growth factor receptor 2 mutation
    Okajima, K
    Robinson, LK
    Hart, MA
    Abuelo, DN
    Cowan, LS
    Hasegawa, T
    Maumenee, IH
    Jabs, EW
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 85 (02): : 160 - 170
  • [42] Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts
    Mansukhani, A
    Bellosta, P
    Sahni, M
    Basilico, C
    JOURNAL OF CELL BIOLOGY, 2000, 149 (06): : 1297 - 1308
  • [43] Pfeiffer's syndrome resulting from an S351C mutation in the fibroblast growth factor receptor-2 gene
    Mathijssen, IMJ
    Vaandrager, JM
    Hoogeboom, AJM
    Hesseling-Janssen, ALW
    van den Ouweland, AMW
    JOURNAL OF CRANIOFACIAL SURGERY, 1998, 9 (03) : 207 - 209
  • [44] Fibroblast growth factor-2 inhibits mineralization of osteoblast-like Saos-2 cells by inhibiting the functioning of matrix vesicles
    Liu, Chao
    Cui, Yazhou
    Luan, Jing
    Zhou, Xiaoyan
    Liu, Zhenxing
    Han, Jinxiang
    DRUG DISCOVERIES AND THERAPEUTICS, 2014, 8 (01): : 42 - 47
  • [45] Aberrantly activated Wnt/β-catenin pathway co-receptorsLRP5andLRP6regulate osteoblast differentiation in the developing coronal sutures of an Apert syndrome (Fgfr2S252W/+) mouse model
    Swe, Nay Myo Min
    Kobayashi, Yukiho
    Kamimoto, Hiroyuki
    Moriyama, Keiji
    DEVELOPMENTAL DYNAMICS, 2021, 250 (03) : 465 - 476
  • [46] Analysis of fibroblast growth factor receptor 3 S249C mutation in cervical carcinoma
    Yee, CJ
    Lin, O
    Boyd, J
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (22): : 1848 - 1849
  • [47] A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis
    Yin, Liangjun
    Du, Xiaolan
    Li, Cuiling
    Xu, Xiaoling
    Chen, Zhi
    Su, Nan
    Zhao, Ling
    Qi, Huabing
    Li, Fubing
    Xue, Jing
    Yang, Jing
    Jin, Min
    Deng, Chuxia
    Chen, Lin
    BONE, 2008, 42 (04) : 631 - 643
  • [48] A novel Fibroblast Growth Factor Receptor 2 (FGFR2) mutation associated with a mild Crouzon syndrome
    Locuratolo, N.
    Baffico, M.
    Baldi, M.
    Parisi, V.
    Micacchi, F.
    Angelucci, V.
    Beccaglia, M. Rojas
    Pirro, C.
    Fattapposta, F.
    ARCHIVES ITALIENNES DE BIOLOGIE, 2011, 149 (03): : 313 - 317
  • [49] Enrolling a rare patient population: Establishing proof of concept for FP-1039, an FGF "trap," in endomeirial cancer patients with the S252W FGFR2 mutation
    Keer, H. N.
    Harding, T. C.
    Kavanaugh, W. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Novel phenotype of craniosynostosis and ocular anterior chamber dysgenesis with a fibroblast growth factor receptor 2 mutation
    McCann, E
    Kaye, SB
    Newman, W
    Norbury, G
    Black, GCM
    Ellis, IH
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2005, 138A (03) : 278 - 281
12345